Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Éditorial
Chronique Mon C**
Alain Lesage, Raymond Morissette
(PDF)

Editorial
Chronic My A**
Alain Lesage, Raymond Morissette
(PDF)

En Revue
Réadaptation Psychiatrique en Milieu Francophone : Pratiques Actuelles, Défis Futurs
Raymond Tempier, Jérôme Favrod
(PDF)

In Review
Rehabilitation in the United Kingdom: Research, Policy, and Practice
Frank Holloway, Jerome Carson, Sarah Davis

(PDF)

Review Papers
Breaking the Myths: New Treatment Approaches for Chronic Depression

Erin E Michalak, Raymond W Lam

(PDF)

Mental Health Reform and Evolution of General Psychiatry In Ontario
John Robert Swenson, Jacques Bradwejn

(PDF)

Original Research
Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario

Elspeth A Bradley, Ann Thompson, Susan E Bryson

(PDF)

Treatment-Seeking Rates and Associated Mediating Factors Among Individuals With Depression
Kristin Bristow, Scott Patten

(PDF)

Brief Communication
Proton Magnetic Resonance Spectroscopy of the Hippocampus and Occipital White Matter in PTSD: Preliminary Results

Gerardo Villarreal, Helen Petropoulos, Derek A Hamilton, Laura M Rowland, William P Horan, Jacqueline A Griego, Margaret Moreshead, Blaine L Hart, William M Brooks

(PDF)

Risperidone Decreases Craving and Relapses in Individuals with Schizophrenia and Cocaine Dependence
David A Smelson, Miklos F Losonczy, Craig W Davis, Maureen Kaune, John Williams, Douglas Ziedonis

(PDF)


CPA Position Paper
The Duty to Protect


APC Énoncé de principe de l’APC
Le devoir de protection


Book Reviews
(PDF)
Hidden Faults: Recognizing and Resolving Therapeutic Disjunctions.

The New Oxford Textbook of Psychiatry

Unfree Associations: Inside Psychoanalytic Institutes

Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy

Forensic Psychiatric Evidence


Letters to the Editor
(PDF)
Catastrophic Reactions Induced by Tetrabenazine

Olanzapine: A Proarrhythmic Drug?

Respiratory Symptoms in Nocturnal Panic Attacks

Carbon Dioxide Test in Respiratory Panic Disorder Subtype

Depression in Multiple Sclerosis Associated With Interferon Beta-1a (Rebif)

Atypical Antipsychotics and Glycemia: A Case Report

Olecranon Bursitis as a Complication of Tardive Dyskinesia

Mental Retardation in Teenagers: Prevalence Data From the Niagara Region, Ontario



Collection of Background Information on Target Population (Participants and Nonparticipants)

We developed a structured questionnaire to collect nonidentifying background information on the nonparticipants. Our main purpose was to determine whether the nonparticipants differed in any significant way from the participants. Information sought included data on the identified individual’s age, sex, adaptive and academic functioning, social and communication skills, and on the education and occupation of the primary caregiver. This was obtained through direct contact with a teacher or service worker who knew the individual well and who was able to provide relevant descriptions without revealing any information that might identify either individuals or their families, thus maintaining complete confidentiality. Information in the same domains of enquiry was collected directly from participants or their caregivers.

Social strata were computed from educational and occupational data on the parents or primary caregiver in the household in which the individual lived or had lived most recently. Following the procedure described by Hollingshead (19), an occupation score (on a scale of 1 to 9) and a level of education score (on a scale of 1 to 7) were combined to provide a social strata score, the range of which is described on a scale of 1 to 5 (1 = major business or professional; 2 = medium business or minor professional or technical worker; 3 = skilled craftsman, clerical, or sales worker; 4 = machine operator or semiskilled worker; 5 = unskilled labourer or menial service worker).

Testing Participants and Screening Nonparticipants to Confirm MR

Measures of nonverbal intelligence included the Performance Scale of the Wechsler Adult Intelligence Scale-Revised (WAIS-R) or Wechsler Intelligence Scale for Children-Revised (WISC-R) and the Merrill-Palmer Scale of Mental Tests (excluding the verbal items) for less-capable individuals. The Peabody Picture Vocabulary Test-R (PPVT-R: Form L) provided an estimate of single word receptive vocabulary. Standard scores from the WAIS-R or WISC-R and equivalents from the Merrill Palmer (converted from mental-age scores) were averaged with standard scores from the Peabody (converted from mental-age equivalents, where necessary) to provide a composite (verbal and nonverbal) IQ score.

Background information obtained on nonparticipants was reviewed independently by 2 of the investigators. Each reviewer rated the information for adaptive and academic functioning and social and communication skills, according to criteria for mild-to-profound MR, based on ICD-10 definitions (20) and following operationally defined guidelines (1,21). Borderline MR (adaptive and cognitive functioning in the 76-to-80 IQ range) was defined by 10 criteria of daily living and functional skills. No participant with MR (IQ £ 75) was able to drive a motor vehicle; therefore, nonparticipants reportedly holding a driver’s license were excluded from the group with MR. Cognitive and adaptive functioning were rated as shown in Table 1. Agreement between reviewers was greater than 80%; disagreements were discussed and a consensus reached.

Results

Target Population Identification

Research staff were provided with the initials, sex, and birthdate of 635 individuals considered to have developmental problems (see Figure 1). Of these, 149 were duplicates (that is, the same initials were provided from different sources), and 116 were removed because they did not meet age or residency criteria. Of the 370 remaining, 204 individuals or their families indicated an interest in participating (participants); 166 individuals or their families declined (nonparticipants).

After screening for IQ, 33 of the 204 participants had a composite IQ greater than 75, leaving 171 with a composite IQ less than or equal to 75 (these were classified as participants with MR). Background information was sufficiently comprehensive to determine functioning level for 136 (82%) of the 166 nonparticipants. Those remaining (30/166) were randomly assigned to the MR and non-MR groups in the same ratio as the 136 individuals for whom there was comprehensive background information. Review of the 166 nonparticipants consequently identified 84 (51%) individuals with MR (defined as nonparticipants with MR) and 82 (49%) individuals without MR. Overall, the study (target) population comprised all 255 individuals aged 14 to 20 years who met criteria for MR (n = 171 participants with MR; n = 84 nonparticipants with MR. See Figure 1).

Participation Rate

Of the 255 individuals with MR, 171 participated, yielding a participation rate of 67%. Background information was available for all participants with MR and for 76% of nonparticipants with MR (64/84), which represents 92% of the total group of 255.

Comparison of Participants with MR and Nonparticipants with MR

Age, Sex, and Level of Functioning. There were no significant differences between participant and nonparticipant MR groups (Table 2).

Social Strata. There were more missing social strata data for the nonparticipant MR group (44%, compared with 10% for the participant MR group). Participant and nonparticipant MR groups differed significantly in social strata. In social strata 1, 2, and 3, there was a greater representation of participants with MR (55%) than of nonparticipants with MR (24%) (c2 = 4.92, df 1, P < 0.05).

Prevalence of MR. Based on the most current census data (17), there were 35 485 young persons between age 14 and 20 years, giving an overall MR prevalence rate of 7.18/1000 (95%CI, 6.31 to 8.06/1000), with MMR (IQ = 50 to 75) prevalence estimated at 3.54/1000 and SMR (IQ < 50) prevalence estimated at 3.64/1000 (Figure 2).

Age-Specific Rates

Figure 2 also shows age-specific prevalence rates. More individuals were represented at the younger ages (that is, 14 to 16 years vs 17 to 20 years), but the difference is not significant.

Age and Functioning Level

There were no significant differences between the number of individuals with mild and severe MR at each age. The number of identified individuals with MMR gradually declines with age (from 19% at age 15 years to 11% at age 20 years); no such trend is evident for those with SMR (15% at age 15 years and 14% at age 20 years). This pattern is likely related to the end of mandatory schooling at age 16 to 17 years, when individuals who are more capable outside an academic setting are less likely to be identified as having MR.

Sex and Functioning Level

Male subjects outnumbered female subjects at all age levels, except at age 19 years. The overall male-to-female ratio was 1.3:1.0. However, functional level varied significantly with sex (c2 = 4.66, df 1, P < 0.05): there were more female subjects with SMR (56% female, compared with 44% male) and a greater number of male subjects with MMR (58% male, compared with 42% female).

Social Strata and Functioning Level

Although none of the differences reached significance, individuals with MMR tended to congregate in the less-advantaged social strata (that is, 4 and 5, but also 2), and those with SMR in strata 1 and 3. There also was a trend toward more male subjects than female subjects in social strata 1 to 4 and more female subjects in social stratum 5.

Discussion

Our prevalence estimate of 3.64/1000 for SMR is similar to rates reported in earlier studies conducted in Canada and elsewhere. Estimates for SMR derived from Canada more than 20 years ago include 3.8/1000 (14), 3.7/1000 (15), and a lower 2.2/1000 (16). In their metaanalysis of prevalence studies conducted between 1960 and 1986, Roeleveld and others concluded that the rate for SMR in school-age children was relatively stable—around an average of 3.8/1000 (6). In a more recent US study carried out in Atlanta, Georgia, the prevalence of SMR was 3.6/1000 for children aged 10 years in the period 1985 to 1987 (22). Abramowicz reviewed studies conducted before 1960 and reported a median prevalence rate for children with SMR of 3.7/1000 (7). A follow-up study by Richardson and Koller of children in Aberdeen at age 22 years, born during 1952 to 1954, and initially studied at age 8 to 10 years, found age-specific prevalence rates of 3.3/1000 at age 8 and 9 years and 2.8/1000 at age 22 years, the drop in rate being almost exclusively due to mortality (12). Our SMR rates for age 14 to 20 years ranged from 2.80/1000 to 4.35/1000, according well with the findings of Richardson and Koller (12). They also underscore that the prevalence of SMR is relatively stable, not only across age but also across time.

For individuals with SMR, the disabilities usually necessitate special supports and services. In epidemiological studies of SMR, the condition has often been defined and identified according to the level of service need. Therefore, for SMR ascertainment prevalence is considered to be a reasonable estimate of true prevalence. Our finding of an SMR rate similar to that reported in other studies confirmed to us that our procedure for case identification of MR was sufficiently comprehensive and inclusive. This was corroborated by the fact that 23% of our initial referrals were duplicates from various sources.

Our finding of 3.54/1000 for MMR is in the lower end of the range established in previous studies (6,11). Low rates raise concerns about whether ascertainment is incomplete (and underestimates true prevalence) or whether such rates indeed reflect the true prevalence, which is lower as a result of such factors as an upward drift in IQ related to improved environments or policies of integration. Because we consider our cacase-identification procedure to have been sufficiently comprehensive (see above), we look to other such explanations for the low MMR prevalence rate found in our study.

Our MMR prevalence estimate is similar to the lower rates generally found in Scandinavian studies (6). In Sweden, these low rates are thought to partly reflect the long-standing tradition of not institutionalizing individuals with MR unless absolutely necessary. Of those persons identified with MR in the Swedish studies, most are judged as having SMR and only 25% as having MMR (23). This is in stark contrast to figures reported from the US, where the reverse situation prevails: 75% have been identified as mildly retarded and 25% as severely retarded (23). Murphy and others report a more recent US prevalence estimate of 8.4/1000 for MMR, which represents 70% of the overall MR prevalence of 12/1000 (22).

Differing prevalence rates between the US and Sweden have been attributed to attitudes, practices, social policies, and allocation of resources. In the Swedish welfare system, service need rather than IQ or diagnosis determines eligibility for benefits. Sonnander and others studied a group of over 8000 pupils aged 12 to 13 years and identified those who met the psychometric criterion for MR but who were not administratively classified as such (n = 116) (24). Combining the numbers in this latter group (116/8000 or 14.5 per 1000) with those identified by school personnel as having MR (7.4/1000) yields a prevalence of 21.9/1000 or 2.19%—close to the expected or true prevalence estimate (23).

Sweden’s philosophy of including and integrating persons with MR spread to Ontario and the rest of Canada in the 1960s (25). The individuals in our study cohort have experienced an education policy of support and integration throughout their school careers. In Ontario, children with MR are educated in regular classes wherever possible. For those with SMR, other options may be available (for example, self-contained schools or special classes in regular schools). However, parental preference takes priority, and even the most disabled child will be accommodated in the regular classroom at the parents’ request. Children with milder disabilities (MMR) are usually found in mainstream classes, although they may follow a modified program and be evaluated on this at graduation. If children are having difficulties in class (for example, in learning or behaviour), they are referred for remedial support and sometimes for psychological testing. Many may remain in the remedial category and may never be identified as having MR. The teacher’s perception of the problem, the psychological resources available to the school, and a moratorium on labelling a child as having MMR are key in the extent to which children will be identified. Our study in Niagara relied on school personnel flagging those children thought to have MR. Of the children flagged, 31% were found not to have MR, suggesting that other factors were affecting teacher selection (we are analyzing these false positives to identify characteristics that flagged these children as having MR). We do not have data on the number of children who psychometrically may have met criteria for MMR but were not flagged by teachers, presumably because, as has been found in Sweden, their adaptive behaviour did not distinguish them from their peers.

Our study results are similar to the Swedish studies in the following other findings: in our ratio of 1.3 male subjects to 1.0 female subjects, in a greater contribution of SMR to the overall prevalence rate, and in our finding of more male subjects with MMR and more female subjects with SMR (26). We conclude that, while prevalence rates for SMR are relatively stable across geographic locations, rates for MMR vary—not least because of prevailing philosophies of care and integration, as well as resources available to implement these philosophies. What evidence is available suggests that the low prevalence of MMR in our study is linked to the policies of integration in Ontario over the past 3 decades—policies that may have made persons with MMR less visible.

1 | 2 | 3 | 4

 


CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2001 | Index RCP des auteurs 2001
Subject Index to 2001 | Index RCP des sujets 2001
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil